Analysis of methylation features associated with neoadjuvant efficacy in HER2-positive breast cancer
{{output}}
Background: Response to trastuzumab-based neoadjuvant therapy in human epidermal growth factor receptor type 2 (HER2)-positive breast cancer is affected by multiple features of the tumor. Few studies have investigated epigenetic ... ...
